| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |